Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2023年11月29日 - 10:35PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
6-K
REPORT
OF FOREIGN PRIVATE ISSUER
PURSUANT
TO SECTION 13A-16 OR 15D-16
UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For
the month of November 2023
Commission
File Number: 001-41316
Alpha
Tau Medical Ltd.
(Exact
Name of Registrant as Specified in Its Charter)
Kiryat
HaMada St. 5
Jerusalem,
Israel 9777605
+972
(3) 577-4115
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
CONTENTS
On November 29, 2023, Alpha
Tau Medical Ltd. (the “Company”) issued a press release titled “Alpha Tau to Participate in Sidoti Small-Cap Conference.”
A copy of this press release is attached to this Form 6-K as Exhibit 99.1.
The information in this Report on Form 6-K, including
in Exhibit 99.1 attached hereto is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities
Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall
it be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange
Act, except as otherwise set forth herein or as shall be expressly set forth by specific reference in such a filing.
EXHIBIT
INDEX
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.
|
Alpha
Tau Medical Ltd. |
|
|
|
Date:
November 29, 2023 |
By: |
/s/
Uzi Sofer |
|
|
Uzi
Sofer |
|
|
Chief
Executive Officer |
3
Exhibit
99.1
Alpha
Tau to Participate in Sidoti Small-Cap Conference
JERUSALEM,
November 29, 2023 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (“Alpha Tau”, or the “Company”) (NASDAQ: DRTS, DRTSW),
the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, today announced
that management will present at the Sidoti Small-Cap Virtual Conference on Thursday, December 7th, 2023.
Format: |
Presentation
and 1-on-1 meetings |
Date: |
December
7th, 2023 |
Time: |
9:15
AM ET |
Location: |
Virtual |
Registration: |
https://sidoti.zoom.us/webinar/register/WN_VNDWwCEtSeySoAVKVx38YQ |
About
Alpha Tau Medical, Ltd.
Founded
in 2016, Alpha Tau is an Israeli medical device company that focuses on research, development, and potential commercialization of the
Alpha DaRT for the treatment of solid tumors. The technology was initially developed by Prof. Itzhak Kelson and Prof. Yona Keisari from
Tel Aviv University.
Investor
Relations Contact:
IR@alphatau.com
Alpha Tau Medical (NASDAQ:DRTS)
過去 株価チャート
から 11 2024 まで 12 2024
Alpha Tau Medical (NASDAQ:DRTS)
過去 株価チャート
から 12 2023 まで 12 2024